Xintong Medical-B (02160.HK): The first half of the year met expectations and continued TAVR release
中金公司Sep 5, 2023 13:42
Xintong Medical (2160.HK) Company Review: Continued expansion of core products and internationalization ready to go
華安證券Sep 4, 2023 00:00
MICROPORT CARDIOFLOW MEDTECH(2160.HK):1H23 RESULTS INLINE;MAINTAINING GUIDANCE OF 4 000+ IMPLANTS IN 2023
中银国际Sep 1, 2023 14:32
Xintong Medical-B (02160.HK): An Innovative Heart Valve Interventional Diagnosis and Treatment Platform
華安證券Aug 4, 2023 16:51
Xintong Healthcare (2160.HK): Revenue in 2022 is in line with expectations, partly due to the expansion of non-cash and one-time projects
浦銀國際Mar 1, 2023 00:00
Xintong Medical-B (02160.HK): 1H22 performance meets expectations for R&D pipelines and overseas progress
中金公司Sep 1, 2022 00:00
Xintong Medical-B (02160.HK): Under the epidemic, the company is operating steadily, and research pipelines are being enriched to create long-term growth space
東吳證券Aug 30, 2022 00:00
Xintong Medical-B (02160.HK): Steady increase in operating income and continuous increase in gross margin
興業證券Aug 30, 2022 00:00
Xintong Medical-B (2160.HK): After the launch of TAVR products, the product pipeline under development was quickly released and there is a rich pipeline
中信建投證券Mar 31, 2022 13:11
Xintong Medical-B (02160.HK): Performance Meets Our Expectations, VITAFLOW Accelerates Release
東吳證券Aug 30, 2021 00:00
Xintong Medical-B (02160.HK): 1H21 performance is slightly lower than market expectations for the second half of the year
中金公司Aug 30, 2021 00:00
Xintong Medical-B (02160.HK): Building a comprehensive treatment platform for heart valve intervention to rapidly increase market share
中金公司Aug 12, 2021 00:00
Xintong Healthcare (2160.HK): First come, first, heart valve treatment innovators set sail
東吳證券Apr 15, 2021 00:00
Xintong Medical-B (02160.HK): the performance is in line with the expected sales volume of TAVI products.
中金公司Mar 31, 2021 00:00
Xintong Medical-B (02160.HK): Striving to become a comprehensive interventional treatment platform for valvular heart disease in China
中金公司Mar 24, 2021 00:00
Xintong Healthcare (02160.HK): Innovation Leads the Future Rise of Local Heart Valve Leaders
興業證券Jan 29, 2021 00:00
Minimally Invasive Xintong Medical Technology Co., Ltd. (2160.HK): IPO Report
中泰國際Jan 26, 2021 00:00
新股认购:心通医疗-B(02160.HK)
财通国际Jan 26, 2021 00:00
IPO News: Minimally Invasive Xintong Medical Technology Co., Ltd. - B (2160.HK)
致富證券Jan 26, 2021 00:00
No Data
No Data